Exiqon
Home Contact Print
Personalized Diagnostics Published Studies Resources Contact Us PortiQo™ Login ArQive™ Registry
Information for Physicians
Information for Patients
Molecular Diagnostics
Licenses and Certifications
Order forms
Bibliography
KRAS Mutation Analysis
BRAF Mutation Analysis
Inquiries and Questions
Contact our global team of research specialists by phone
or use our contact form .
Headquarters
Exiqon A/S
Skelstedet 16
2950 Vedbaek
Denmark
Phone: +45 45 66 08 88
Fax: +45 45 66 18 88
CVR/Tax Id: 18 98 44 31
North America
Exiqon Inc.
15501 Red Hill Avenue
Tustin, CA 92780
USA
Phone: (800) 576-6326
(714) 566-0420
Fax: (714) 566-0421
Client Services
Phone: (800) 662-6832
Fax: (714) 566-0423
The Company offers a broad range of clinical laboratory services including the Oncotech EDR® Assay and molecular biomarker testing. By utilizing proprietary Locked Nucleic Acids (LNA™) technology and miRNA biomarkers, Exiqon Diagnostics is establishing the next generation of molecular diagnostics for oncology. Exiqon Diagnostics has performed oncology services for more than 100,000 cancer patients from over 1,000 hospitals throughout North America and Europe. Exiqon Diagnostics is the trade name for Oncotech, Inc., a wholly owned subsidiary of Exiqon A/S. 
 
Welcome to Exiqon Life Sciences  

Innovative Molecular Oncology Testing Services for the Benefit of Cancer Patients. 

Exiqon Diagnostics, a wholly owned subsidiary of Exiqon A/S, is a leader in personalizing medicine for cancer patients. Exiqon Diagnostics is dedicated to developing and performing novel molecular and cell-based oncology assays to help physicians individualize and optimize treatment selection for their patients. 

arrow-bullet   ONCOTECH is now Exiqon Diagnostics!

To read more about the announcement, please click here.

To view the customer notification letter, please click here.

For a list of Customer FAQs regarding the transition, please click here.
  Privacy   Sitemap   Legal   Webmail